Clinical Trial Update: Role of Barrier Resection in Local Control for Extremity Recurrent Soft Tissue Sarcomas [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial evaluating barrier resection for local control in patients with extremity recurrent soft tissue sarcoma; sponsor i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: Fudan University | Conditions: Local Recurrence of Malignant Tumor of Soft Tissue | Phase 3 | Status: UNKNOWN